Quince Therapeutics IRLA

Sofinnova Capital VIII updates its stake in Quince Therapeutics to 2.7%

Form
Schedule 13G/A
Filed
Importance
Routine
Exhibit 99.1
Press release

Not explained yet; the original is on EDGAR.

Ownership stake disclosure (amended)

Get an email when Quince Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.